Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 16, 2010
FDA approval is based on results from the Company's landmark MADIT-CRT trial
-
Sep 14, 2010
Company to present clinical data on its platinum chromium PROMUS® Element™ and TAXUS® Element™ Coronary Stent Systems
-
Sep 2, 2010
Company to participate in the September 14th conference in New York City; live webcast and replay will be available
-
Aug 19, 2010
Presentations to feature Boston Scientific's pelvic floor reconstruction systems and mid-urethral sling systems
-
Aug 11, 2010
Resolution "marks a major milestone in our journey of continuous quality improvement," said Ray Elliott, President and Chief Executive Officer
-
Aug 3, 2010
EVOLVE trial to evaluate Company's fourth-generation SYNERGY™ drug-eluting coronary stent
-
Jul 29, 2010
Company now offers pain specialists the most comprehensive portfolio of SCS percutaneous leads
-
Jul 29, 2010
Company to participate in the August 5th conference in New York; live webcast and replay will be available
-
Jul 26, 2010
Company expands market-leading family of neurovascular stents
-
Jul 20, 2010
"I am proud of the way the organization executed in a number of key areas during the quarter," said Ray Elliott, President and CEO